Dr. Diana Marangu-Boore is a board certified paediatric pulmonologist affiliated with the University of Nairobi in Kenya. She is committed to improving respiratory health regionally and globally through discovery, translation and intervention. Her current research focuses on the genetics and immunology of recurrent and persistent pneumonia and its intersection with interventional pulmonology.

Sandra Kwarteng Owusu is a Paediatric Pulmonologist and a Senior Lecturer at the Department of Child Health, School of Medical Sciences at the Kwame Nkrumah University of Science and Technology in Kumasi Ghana. She is also a Consultant Paediatrician at the Komfo Anokye Teaching Hospital (KATH) in Kumasi. Sandra established the first Paediatric Pulmonology service at the (KATH) after her training in Cape Town South Africa. She has established a multi-disciplinary paediatric respiratory team. Her research work is focused on lung health conditions in childhood such as; asthma, pneumonia, tuberculosis, HIV, and sickle cell disease. She also works on air pollution and its impact on lung health. Sandra is an ordinary executive member of the Pan African Thoracic Society and Vice President of the Ghana Thoracic Society. She worked closely with the society to develop the National Asthma Guidelines for Ghana. She is collaborating with the Pan African Thoracic Society in the ongoing multicenter study- Chronic Respiratory Disease Observatory (CHEST AFRICA study)

Professor in Paediatrics, Head of the Department of General Pediatrics, University Childrens Hospital Münster, Germany. Fellow of the European Respiratory Society (ERS), Member of the North Rhine Westphalian Academy of Sciences and Arts and of the Leopoldina National Academy of Sciences. Coordinator of the European Reference Network for rare respiratory diseases (ERN-LUNG) PCD Core. Research interests: • Lead of the International PCD Registry established within the EU funded project BESTCILIA • Member of the Executive Committee of the Clinical Trial network for Primary Ciliary Dyskinesia (PCD-CTN) founded in 2020. • Medical advisor of the Kartagener Syndrom und Primäre Ciliäre Dyskinesie e. V. and US PCD Foundation. • Gene discovery of Genotype-phenotype-correlations of PCD. • Development of novel diagnostic tests for PCD. • Development of mRNA based therapies for treatment of PCD.